Page 12 - Generics Access Project News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Generics access project. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Generics Access Project Today - Breaking & Trending Today

Weak pharma growth in Q2 sparks concerns

Weakness in domestic growth is driven by slow growth in the acute segment ....

Prashant Nair , Sun Pharma , Ajanta Pharma Ltd , Kotak Institutional Equities , Antique Stock , Ambit Capital , Torrent Pharma , June Quarter , Nifty Pharma Index , Jm Financial , Ajanta Pharma ,

AAM Report: Generics and Biosimilars Generate $408 Billion in 2022

A report from the Association for Accessible Medicines (AAM) highlighted the value of biosimilars and generics, revealing that lower-cost versions of originator products accumulated $408 billion for the US health care system in 2022. ....

United States , West Virginia , New York , David Gaugh , Association For Accessible Medicines , American Journal , Accessible Medicines , Biosimilar Medicines Savings Report , Hatch Waxman Act ,

FTC Warns Drugmakers Over Patent Listings: Statement

The US Federal Trade Commission has warned brand-name drugmakers they could face legal action if they improperly list patents with federal health regulators. ....

United States , Doina Chiacu , Drug Administration , Us Federal Trade Commission On , Trade Commission , Orange Book , Susan Heavey , Drug Regulation , Generic Drug , Eneric Medication ,

New Evidence Early Tx Improves Preclinical MS Outcomes

The disease-modifying drug teriflunomide reduces the risk of developing clinical multiple sclerosis by 72% in radiologically isolated syndrome. ....

Christine Lebrun , University Of Nice , Syndrome Consortium , University Cote , University Hospital Of Nice , Radiologically Isolated Syndrome , Christine Lebrun Fr , University Hospital , Multiple Sclerosis Ms , Multiple Sclerosis , Clinical Research , Clinical Trials , Linical Studies , Liver Enzymes , Liver Studies , Central Nervous System , Generic Drug , Eneric Medication , Respiratory Infections , Healthcare And Medical Technology , Ealth And Medical Tech ,

BMS Accused of Illegal Tactics to Keep Pomalyst Monopoly

Bristol Myers Squibb has been accused in a new lawsuit of using fraudulent patents and other illegal tactics to maintain its monopoly on blockbuster blood cancer drug Pomalyst. ....

New York , United States , Aurobindo Pharma , Brendan Pierson , Bristol Myers , Natco Pharma , Alexia Garamfalvi , Bristol Myers Squibb , Trademark Office , Teva Pharmaceutical Industries , Myers Squibb , Blue Cross Shield , Sherman Act , Breckeridge Pharmaceutical , Cross Blue Shield , Reporting By Brendan Pierson , Bill Berkrot , Multiple Myeloma , Plasma Cell Myeloma , Generic Drug , Eneric Medication , Alignant Neoplasia ,